Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment-Reference-Cited by-同舟云学术

Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment

Published:2022-01-31 Issue:3 Volume:3 Page:318-336
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Falcomatà Chiara,Bärthel Stefanie^ORCID,Widholz Sebastian A.^ORCID,Schneeweis Christian,Montero Juan José,Toska Albulena^ORCID,Mir Jonas^ORCID,Kaltenbacher Thorsten^ORCID,Heetmeyer Jeannine,Swietlik Jonathan J.,Cheng Jing-Yuan^ORCID,Teodorescu Bianca,Reichert Oliver,Schmitt Constantin,Grabichler Kathrin,Coluccio Andrea,Boniolo Fabio,Veltkamp Christian,Zukowska Magdalena,Vargas Angelica Arenas,Paik Woo Hyun^ORCID,Jesinghaus Moritz^ORCID,Steiger Katja^ORCID,Maresch Roman,Öllinger Rupert,Ammon Tim,Baranov Olga,Robles Maria S.,Rechenberger Julia,Kuster Bernhard^ORCID,Meissner Felix,Reichert Maximilian,Flossdorf Michael,Rad Roland^ORCID,Schmidt-Supprian Marc,Schneider Günter^ORCID,Saur Dieter^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-021-00326-1.pdf

Reference77 articles.

1. Quaresma, M., Coleman, M. P. & Rachet, B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. Lancet 385, 1206–1218 (2015).

2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).

3. Aung, K. L. et al. Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial. Clin. Cancer Res. 24, 1344–1354 (2018).

4. Kalimuthu, S. N. et al. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome. Gut 69, 317–328 (2020).

5. Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet. 52, 231–240 (2020).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS^G^12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening;Molecular Oncology;2024-09-10

2. Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis;Science;2024-09-05

3. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment;Nature Genetics;2024-09-03

4. Time – The fourth dimension of immune cells;MedComm;2024-08

5. Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era;International Journal of Molecular Sciences;2024-07-11